NBS10

Lisata Therapeutics, Inc. · Phase 2 active Biologic

At a glance

Generic name	NBS10
Also known as	AMR-001
Sponsor	Lisata Therapeutics, Inc.
Modality	Biologic
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

NBS10 CI brief — competitive landscape report
NBS10 updates RSS · CI watch RSS
Lisata Therapeutics, Inc. portfolio CI